Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Mirxes Holding Company Limited ( (HK:2629) ) is now available.
Mirxes Holding Company Limited has entered into a memorandum of understanding with XtalPi Holdings Limited to integrate their strengths in genomics technology and AI-driven drug discovery. This collaboration aims to develop an AI-enabled platform for early diagnosis and intervention of Asian high-incidence cancers, particularly gastrointestinal cancers, enhancing precision medicine approaches and creating synergies in cancer diagnostics and treatment within the Asia-Pacific region.
More about Mirxes Holding Company Limited
Mirxes Holding Company Limited operates in the genomics technology industry, focusing on early detection and intervention solutions for high-incidence cancers, particularly gastrointestinal cancers, using its extensive disease database centered on Asian populations.
Average Trading Volume: 1,777,828
Technical Sentiment Signal: Hold
Current Market Cap: HK$13.71B
See more data about 2629 stock on TipRanks’ Stock Analysis page.